PHAXIAM Therapeutics Stock Quote PHXM - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.1515

Bid

0.15

Ask

0.1635

Volume

234,797

0.149 Day's Range 0.1685

0.149 52 Week Range 3.08

Market Cap

4.695M

Previous Close

0.58

Open

0.149

Last Trade

0.1515

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

41,890

Shares Outstanding

30,989,584

Dividend Yield

PE Ratio

-0.20

Earnings Per Share (EPS)

-0.76

Revenue

1.33M

Net Profit

-23.49M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phaxiam.com

Headquarters

Lyon, Rhone, Fra

Founded

PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 0.58 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 0.149 € to 3.08 €.

PHAXIAM Therapeutics currently has 30,989,584 shares outstanding. The market capitalization of PHAXIAM Therapeutics is 17.97 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -0.20.

PHAXIAM Therapeutics : Point sur la procédure de redressement judiciaire

Regulatory News: PHAXIAM Therapeutics (Euronext : PHXM - FR001400K4B1), ci-après « la Société » ou « PHAXIAM », société biopharmaceutique...

PHAXIAM fait le point sur le déploiement de sa stratégie permettant de maximiser le potentiel de développement de la phagothérapie

Stratégie articulée autour de deux axes de développement complémentaires, thérapies individualisées à base de phages BPF (IPT) et...

PHAXIAM Therapeutics and Technophage Enter Strategic Collaboration On Individualized GMP Phages Therapies (IPT) Against Bacteria Responsible For ~ 70%(1) Of The Most Common Severe Resistant Infections

Combined 25 GMP(2) Phages Portfolio to cover by end 2025 five of the most critical pathogens (S. aureus, P. aeruginosa, E. coli, K. pneumoniae...

PHAXIAM Therapeutics Announces Its Financial Calendar for 2025

Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM – FR0011471135), a biopharmaceutical company developing innovative treatments for severe...

PHAXIAM Therapeutics Announces Updated Real-Life Clinical Data From Patients Treated Under the Compassionate Status in Europe

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.5285	-77.7205882353	0.68	0.68	0.149	56234	0.59779781	DE
4	-0.3805	-71.522556391	0.532	0.8	0.149	34526	0.63876347	DE
12	-1.6645	-91.6574889868	1.816	1.94	0.149	41890	0.98545009	DE
26	-1.5665	-91.1816065192	1.718	2.145	0.149	26132	1.21449643	DE
52	-2.7535	-94.7848537005	2.905	3.08	0.149	16516	1.43915823	DE
156	-0.6385	-80.8227848101	0.79	6	0.149	26565	1.16278024	DE
260	-0.6385	-80.8227848101	0.79	6	0.149	26565	1.16278024	DE

PHXM - Frequently Asked Questions (FAQ)

What is the current PHAXIAM Therapeutics share price?

The current share price of PHAXIAM Therapeutics is 0.1515 €

How many PHAXIAM Therapeutics shares are in issue?

PHAXIAM Therapeutics has 30,989,584 shares in issue

What is the market cap of PHAXIAM Therapeutics?

The market capitalisation of PHAXIAM Therapeutics is EUR 17.97M

What is the 1 year trading range for PHAXIAM Therapeutics share price?

PHAXIAM Therapeutics has traded in the range of 0.149 € to 3.08 € during the past year

What is the PE ratio of PHAXIAM Therapeutics?

The price to earnings ratio of PHAXIAM Therapeutics is -0.2

What is the cash to sales ratio of PHAXIAM Therapeutics?

The cash to sales ratio of PHAXIAM Therapeutics is 3.5

What is the reporting currency for PHAXIAM Therapeutics?

PHAXIAM Therapeutics reports financial results in EUR

What is the latest annual turnover for PHAXIAM Therapeutics?

The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M

What is the latest annual profit for PHAXIAM Therapeutics?

The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M

What is the registered address of PHAXIAM Therapeutics?

The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the PHAXIAM Therapeutics website address?

The website address for PHAXIAM Therapeutics is www.phaxiam.com

Which industry sector does PHAXIAM Therapeutics operate in?

PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALSENSensorion	0.2092 € (34.53%)	2.23M
EBUSEbusco Holding NV	0.6485 € (27.66%)	5.29M
MLFXOFinaxo	2.26 € (19.58%)	808
MLSMLSmalto	0.015 € (15.38%)	2k
ALLDLLDLC Groups	7.70 € (14.93%)	24.07k
PHXMPHAXIAM Therapeutics SA	0.1515 € (-73.88%)	234.8k
ALCHIAlchimie	0.231 € (-42.25%)	365.3k
ALNEVNeovacs	0.013 € (-23.08%)	3.18M
ALOKWGroupe Okwind SA	1.57 € (-21.18%)	61.01k
MLNMAMiguet Et Associes	0.15 € (-20.21%)	250
ALEUPEuroplasma	0.017 € (11.11%)	326.62M
ALVERVergnet	0.0007 € (0.00%)	294.39M
ALALOAcheterLouerFR	0.0004 € (-20.00%)	270.92M
ALHPIHopium SA	0.0009 € (-10.00%)	109.33M
BCPBanco Comercial Portugues SA	0.5684 € (1.97%)	57.02M